Symposia: Allogeneic Transplantation: Disease Response and Comparative Treatment Studies
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Combination therapy, AML, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bone Marrow Failure Syndromes, Bispecific Antibody Therapy, Lymphomas, Non-Hodgkin lymphoma, MPN, Translational Research, Chemotherapy, Aplastic Anemia, Clinical Research, Health outcomes research, Diversity, Equity, and Inclusion (DEI), Chronic Myeloid Malignancies, Health disparities research, Pediatric, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Immunotherapy, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Registries, Myeloid Malignancies, Technology and Procedures, Study Population, Human, Measurable Residual Disease , Machine learning, Transplantation (Allogeneic and Autologous), Serologic Tests
Type: Poster
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Combination therapy, AML, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bone Marrow Failure Syndromes, Bispecific Antibody Therapy, Lymphomas, Non-Hodgkin lymphoma, MPN, Translational Research, Chemotherapy, Aplastic Anemia, Clinical Research, Health outcomes research, Diversity, Equity, and Inclusion (DEI), Chronic Myeloid Malignancies, Health disparities research, Pediatric, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Immunotherapy, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Registries, Myeloid Malignancies, Technology and Procedures, Study Population, Human, Measurable Residual Disease , Machine learning, Transplantation (Allogeneic and Autologous), Serologic Tests
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH